Populations in low resource settings need easy access to continued healthcare and medical treatments and there are many contributing factors as to why there is an imbalance when it comes to demand and accessibility.
The development of nanomaterial catalysts to reduce the emissions in engine exhaust fumes is critical for a sustainable future. New catalysts are needed which are capable of working over a wider range of temperatures while minimising precious metal usage.
Cancer in its entirety accounts for 28% of deaths each year in the UK, according to Cancer Research UK data. To design better treatments for cancer, a new, patient-derived “organoid” (’mini organ’) model system has been developed for drug testing.
The accumulation, in the environment and in human food supply chain, of organic micropollutants, drugs, hormones or endocrine disruptors, represents today one of the biggest challenges to public health and the environment in the EU and elsewhere.